{"filings":[{"id":92286,"accession_number":"0001333493-26-000025","cik":1333493,"company_name":"eHealth, Inc.","ticker":"EHTH","form_type":"8-K","filed_at":"2026-05-06T23:59:59+00:00","items":["2.02","5.02","9.01"],"status":"ready","headline":"eHealth Q1 2026 revenue falls 22% to $88M; GAAP net loss $4.7M, adj. EBITDA $9M","event_type":"earnings","confidence":"high","bullets":["Q1 total revenue $88.0M (-22% YoY); GAAP net loss $4.7M vs net income $2.0M in Q1 2025.","Adjusted EBITDA $9.0M (10% margin), down 28% YoY; total operating costs down 16% to $90.9M.","Medicare segment gross margin improved to 41% from 34%; LTV-to-CAC ratio 1.4x vs 1.2x.","Board member Cesar Soriano resigned effective prior to June 18 annual meeting; no disagreement.","Company on track to cut FY 2026 operating costs ~$90M; launched lifetime advisory model and final expense insurance."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.58,"consensus_revenue_estimate":null,"consensus_revenue_actual":88018000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.7,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":103037,"accession_number":"0001333493-26-000014","cik":1333493,"company_name":"eHealth, Inc.","ticker":"EHTH","form_type":"8-K","filed_at":"2026-03-31T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Director Andrea Brimmer will not stand for re-election at eHealth's 2026 annual meeting","event_type":"leadership","confidence":"high","bullets":["Andrea Brimmer notified eHealth of her decision not to stand for re-election as director.","Her term expires at the annual meeting scheduled for June 18, 2026.","Brimmer served on the board for nearly eight years; departure not due to any disagreement.","CEO Derrick Duke thanked Brimmer for her leadership and contributions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":103036,"accession_number":"0001333493-26-000007","cik":1333493,"company_name":"eHealth, Inc.","ticker":"EHTH","form_type":"8-K","filed_at":"2026-02-25T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"eHealth Q4 2025 revenue $326.2M (+4% YoY); adj. EBITDA $132.9M (+10%); commissions receivable $1.1B","event_type":"earnings","confidence":"high","bullets":["Q4 GAAP net income $87.2M vs $97.5M YoY; FY 2025 GAAP net income $40.0M, up from $10.1M.","Q4 adjusted EBITDA $132.9M (+10% YoY); FY adjusted EBITDA $97.3M (+40%).","Commissions receivable $1.1B at Dec 31, 2025, up 12% YoY; Medicare LTV-to-CAC ratio improved to 2.2x from 2.0x.","Replaced $70M term loan with $125M asset-backed revolving credit facility maturing Dec 2028.","Launched AI voice agent at scale during Medicare AEP; total MA submissions down 4% in Q4."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.34,"consensus_revenue_estimate":null,"consensus_revenue_actual":554008000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":103035,"accession_number":"0001333493-26-000003","cik":1333493,"company_name":"eHealth, Inc.","ticker":"EHTH","form_type":"8-K","filed_at":"2026-01-06T23:59:59+00:00","items":["1.01","1.02","2.03","3.03","5.03","7.01","9.01"],"status":"ready","headline":"eHealth closes $125M asset-based revolver with Manulife | Comvest; repays $70M Blue Torch Loan","event_type":"debt","confidence":"high","bullets":["New $125M revolving credit facility matures Dec 2028; SOFR + 6.50% interest rate, lower than prior term loan.","Proceeds used to repay $70M outstanding under Blue Torch term loan; balance for AI, omni-channel, and growth initiatives.","Borrowing base includes up to $50M cash plus net commission streams; option to increase commitments by $50M.","Amendment to H.I.G. investment agreement permits the facility, adds strategy committee with H.I.G. designee.","Liquidity covenant breach triggers 2% increase in PIK dividend rate on Series A preferred stock until cured."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.85,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":119266,"accession_number":"0001333493-25-000115","cik":1333493,"company_name":"eHealth, Inc.","ticker":"EHTH","form_type":"8-K","filed_at":"2025-12-18T23:59:59+00:00","items":["5.03","7.01","9.01"],"status":"ready","headline":"eHealth raises FY2025 guidance after strong AEP; adj. EBITDA guided to $80-95M","event_type":"earnings","confidence":"high","bullets":["Total revenue guidance raised to $540-560M from $525-565M; GAAP net income raised to $30-45M from $9-30M.","Adjusted EBITDA guidance raised to $80-95M from $60-80M; operating cash flow guided to $(25)-$0M.","AEP enrollment volume in line with last year; shift to direct branded channels improved profitability.","Q4 MA constrained LTV expected to see meaningful YoY increase driven by higher commission rates and favorable persistency.","AI screeners deployed to enhance marketing yield and sales efficiency during AEP."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":119265,"accession_number":"0001333493-25-000110","cik":1333493,"company_name":"eHealth, Inc.","ticker":"EHTH","form_type":"8-K","filed_at":"2025-11-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"eHealth raises FY 2025 guidance, Q3 revenue down 8% to $53.9M, net loss improves","event_type":"earnings","confidence":"high","bullets":["Q3 2025 revenue $53.9M, down 8% YoY; GAAP net loss $31.7M vs $42.5M loss in Q3 2024.","Adjusted EBITDA loss improved to $34.0M from $34.8M; operating costs down 6% to $95.4M.","MA approved members declined due to regulatory limits on dual-eligible switches; Med Supp LTV up 33%.","Positive net adjustment revenue of $12.2M vs $1.2M in prior year.","AEP preparations completed; amended term loan to extend maturity to Jan 2027, cash $75.3M."],"consensus_eps_estimate":null,"consensus_eps_actual":-2.78,"consensus_revenue_estimate":null,"consensus_revenue_actual":227770000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":119264,"accession_number":"0001333493-25-000106","cik":1333493,"company_name":"eHealth, Inc.","ticker":"EHTH","form_type":"8-K","filed_at":"2025-10-07T23:59:59+00:00","items":["1.01","2.03","7.01","9.01"],"status":"ready","headline":"eHealth extends term loan maturity to January 2027, reaffirms capital structure objectives","event_type":"debt","confidence":"high","bullets":["Entered Third Amendment to Credit Agreement with Blue Torch Finance LLC; maturity extended to January 29, 2027.","All other key terms including interest rate and outstanding principal amount remain unchanged.","CEO states extension provides financial flexibility; company continues progress on capital strategy.","Capital strategy objectives: term loan maturity (achieved), leverage commissions receivable asset, address Series A preferred stock."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":135829,"accession_number":"0001333493-25-000101","cik":1333493,"company_name":"eHealth, Inc.","ticker":"EHTH","form_type":"8-K","filed_at":"2025-09-19T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"eHealth board changes: Tolson resigns, Arden and Duke appointed","event_type":"leadership","confidence":"high","bullets":["Aaron Tolson resigned from eHealth Board and all committees effective Sept 17, 2025; no disagreement cited.","Todd Arden appointed as Class I director and to Compensation, Nominating, and Gov/Reg committees.","Derrick Duke appointed to Class I director after Board expanded from 9 to 10 members on Sept 18, 2025.","Todd Arden receives $150k RSU grant (3-year vest), pro rata cash retainers, and $35k/month from H.I.G."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":135828,"accession_number":"0001333493-25-000087","cik":1333493,"company_name":"eHealth, Inc.","ticker":"EHTH","form_type":"8-K","filed_at":"2025-08-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"eHealth Q2 revenue $60.8M (-8% YoY), GAAP net loss improves; raises FY2025 guidance","event_type":"earnings","confidence":"high","bullets":["Q2 total revenue $60.8M, down 8% YoY; GAAP net loss $17.4M improved from $28.0M loss.","Raised 2025 annual revenue and earnings guidance due to strong YTD performance.","Medicare variable marketing spend down 24% YoY; MA LTV up 1%, Med Supp LTV up 29%.","Adjusted EBITDA loss $14.1M vs $15.5M loss in Q2 2024.","Cash and marketable securities $105.2M; commissions receivable $917.0M."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.32,"consensus_revenue_estimate":null,"consensus_revenue_actual":173901000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":135827,"accession_number":"0001333493-25-000083","cik":1333493,"company_name":"eHealth, Inc.","ticker":"EHTH","form_type":"8-K","filed_at":"2025-07-29T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"eHealth names Derrick Duke CEO; Fran Soistman to retire effective Sept 18, 2025","event_type":"leadership","confidence":"high","bullets":["Derrick Duke, former CEO of Magellan Health, appointed CEO effective Sept 18, 2025; joins Aug 4 for transition.","Fran Soistman resigns as CEO prior to Sept 18 board meeting, remains executive advisor through Dec 31, 2025 and on board.","Duke receives $700,000 base salary, 120% target annual bonus, $600,000 signing bonus (with repayment clause).","Duke eligible for 300,000 time-based RSUs vesting over 3 years and 300,000 performance-based RSUs (target).","Severance includes 24 months salary plus pro-rated bonus on qualifying termination; change-in-control triggers 24 months salary plus 200% target bonus."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":152816,"accession_number":"0001333493-25-000078","cik":1333493,"company_name":"eHealth, Inc.","ticker":"EHTH","form_type":"8-K","filed_at":"2025-06-24T23:59:59+00:00","items":["5.02","5.07","9.01"],"status":"ready","headline":"eHealth CEO Fran Soistman extends term to Sept 30, 2025; receives $1M retention award","event_type":"leadership","confidence":"high","bullets":["CEO Soistman will stay as CEO until successor appointed or Sept 30, 2025, then serve as Executive Advisor through Dec 31, 2025.","Soistman receives $1M retention cash award (payable Jan 2026) and 2025 performance bonus; no separate annual equity or bonus.","Soistman acknowledges no severance on transition; will continue vesting of existing equity.","Stockholders approved amending 2024 Equity Incentive Plan to add 1.5M shares for future grants.","Directors Hass, Soistman, Tolson re-elected; EY ratified as auditor; say-on-pay approved."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}